In addition, FMT in transgenic AD mouse models reduced inflammation via the TLR4-Myeloid differentiation factor 88 (MyD88)-NF-κB (TLR4/MyD88/NF-κB) pathway and increased SCFA production (67). Here, NFKB1 is linked to Alzheimer disease.